WHO ICTRP trial
A randomised open-label study comparing the safety and efficacy of ritonavir…
ACTRN12609000881235 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12609000881235 |
|---|---|
| Public title | A randomised open-label study comparing the safety and efficacy of ritonavir boosted lopinavir and 2-3 nucleoside reverse transcriptase inhibitors (NRTI) backbone versus ritonavir boosted lopinavir and raltegravir in participants virologically failing first-line non-nucleoside reverse transcriptase inhibitors (NNRTI)/2 NRTI therapy (the SECOND-LINE study). This study is for Human Immunodeficiency Virus (HIV) infection. |
| Scientific title | A randomised open-label study comparing the safety and efficacy of ritonavir boosted lopinavir and 2-3 nucleoside reverse transcriptase inhibitors (NRTI) backbone versus ritonavir boosted lopinavir and raltegravir in participants virologically failing first-line non-nucleoside reverse transcriptase… |
| Primary sponsor | University of New South Wales/Kirby Institute |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Australia;New Zealand;Argentina;Argentina;Argentina;Chile;Peru;Peru;Mexico;Mexico;United Kingdom;Ireland;France;Germany;Germany;Israel;Malaysia;Malaysia;Malaysia;Hong Kong;Taiwan, Province Of… |
| Conditions | Human Immunodeficiency Virus (HIV) -1 infection; Human Immunodeficiency Virus (HIV) -1 infection;Infection - Acquired immune deficiency syndrome (AIDS / HIV) |
| Interventions | This study is a Phase IIIB/IV, randomised, open label comparison of two independent regimens of combination antiretrovirals as second-line therapy following confirmed virological failure of a first-line non-nucleoside and two nucleoside… |
| Registration date | Sep 10, 2009 |
| Target size | 550 |
| Secondary IDs | Kirby Institute;ClinicalTrials.gov number: NCT00931463 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: